What biochemical marker is often associated with cardiac injury?

What biochemical marker is often associated with cardiac injury?

• A. Creatinine
• B. Troponin
• C. B-type natriuretic peptide
• D. Lipid profile

Answer: (B)

Troponin is a crucial biochemical marker used in the assessment of cardiac injury. It is a protein found in cardiac muscle that is released into the bloodstream when there is damage to the heart muscle, often as a result of conditions like myocardial infarction (heart attack). The levels of troponin, particularly troponin I and troponin T, can rise significantly after cardiac damage, making it a sensitive and specific indicator for diagnosing cardiac injury. In contrast to other markers, such as creatinine—which is more related to kidney function—and B-type natriuretic peptide (BNP), which is associated with heart failure, troponin directly correlates with myocardial injury. The lipid profile provides information about cholesterol levels and cardiovascular risk but is not specific to acute injury or damage to the heart muscle. This specificity and sensitivity to cardiac injury make troponin the preferred biomarker in clinical settings for assessing cardiac events.

Troponin is a crucial biochemical marker used in the assessment of cardiac injury. It is a protein found in cardiac muscle that is released into the bloodstream when there is damage to the heart muscle, often as a result of conditions like myocardial infarction (heart attack). The levels of troponin, particularly troponin I and troponin T, can rise significantly after cardiac damage, making it a sensitive and specific indicator for diagnosing cardiac injury.

In contrast to other markers, such as creatinine—which is more related to kidney function—and B-type natriuretic peptide (BNP), which is associated with heart failure, troponin directly correlates with myocardial injury. The lipid profile provides information about cholesterol levels and cardiovascular risk but is not specific to acute injury or damage to the heart muscle. This specificity and sensitivity to cardiac injury make troponin the preferred biomarker in clinical settings for assessing cardiac events.